There has been an increasing demand for the development of nanocarriers targeting
multiple diseases with a broad range of properties. Due to their tiny size, giant surface area …

Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

Intracellular bacteria in latent or dormant states tolerate high‐dose antibiotics. Fighting
against these opportunistic bacteria has been a long‐standing challenge. Herein, the design …

The appearance and rapid spread of drug resistant strains of tuberculosis (TB), one of the
deadliest infectious diseases, pose a serious threat to public health and increase the need …

Biodegradable and biocompatible polymeric nanoparticles (NPs) stand out as a key tool for
improving drug bioavailability, reducing the inherent toxicity, and targeting the intended site …

Pulmonary drug delivery system is increasingly gaining popularity for several lung diseases
including tuberculosis (TB) due to its ability to attain high drug concentrations at the site of …

Self-assembled amphiphilic polymers have been extensively studied for various biomedical
applications, as they show advantageous properties for diagnosis and therapy. In this work …

Tuberculosis is an intracellular infectious disease caused by Mycobacterium tuberculosis,
which mainly affects the lungs. Especially in patients infected by the Human …

Multi-drug combinations are a common strategy for the treatment of intracellular bacterial
infections. However, different internalized pathways and the accumulation of the composite …

Intracellular bacteria often lead to chronic and recurrent infections; however, most of the
known antibiotics have poor efficacy against intracellular bacteria due to their poor cell …